Your institution may have access to this item. Find your institution then sign in to continue.
Title
NCATs drug candidate attracts first buyer.
Abstract
The article offers information on acquisition of a drug candidate developed by the U.S. National Institutes of Health (NIH)'s National Center for Advancing Translational Sciences (NCATs) to treat sickle cell disease by healthcare firm Baxter International's bioscience unit as of September 2014.